MapLight Therapeutics (MPLT) PT Lowered to $20 at BMO Capital Jul 28, 2026 09:13AM
BMO Capital on MapLight Therapeutics (MPLT): 'we contest that opportunity remains in schizophrenia with more upside from Alzheimer's psychosis' Jul 27, 2026 08:15AM
BMO Capital Starts MapLight Therapeutics (MPLT) at Outperform Jul 20, 2026 04:08PM